Cargando…
1018. Prevalence of Bacteremia/Fungemia and Pneumonia in Remission Induction Chemotherapy for Adult Acute Myeloid Leukemia From 1987 to 2005: Japan Adult Leukemia Study Group (JALSG)
BACKGROUND: Remission induction (RI) chemotherapy for acute myeloid leukemia (AML) is one of the most intensive chemotherapy available. Antibiotic prophylaxis and prompt treatment for infectious complications during RI chemotherapy play a major role in supportive care. METHODS: We retrospectively an...
Autores principales: | Kato, Hideaki, Fujita, Hiroyuki, Akiyama, Nobu, Kimura, Shun-Ichi, Hiramoto, Nobuhiro, Hosono, Naoko, Takahashi, Tsutomu, Shigeno, Kazuyuki, Minamiguchi, Hitoshi, Miyatake, Junichi, Handa, Hiroshi, Kanda, Yoshinobu, Yoshida, Minoru, Miyawaki, Shuichi, Ohtake, Shigeki, Naoe, Tomoki, Kiyoi, Hitoshi, Matsumura, Itaru, Miyazaki, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255072/ http://dx.doi.org/10.1093/ofid/ofy210.855 |
Ejemplares similares
-
Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature
por: Takeshita, Akihiro, et al.
Publicado: (2020) -
High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT Study
por: Nishiwaki, Satoshi, et al.
Publicado: (2023) -
Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3‐internal tandem duplication AML: The JALSG AML209‐FLT3‐SCT study
por: Kawashima, Naomi, et al.
Publicado: (2020) -
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL
por: Hatta, Yoshihiro, et al.
Publicado: (2018) -
Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group
por: Hayakawa, F, et al.
Publicado: (2014)